/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Eton Pharmaceuticals Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$16.5 0.0735(7.35%) ETON at 04 Dec 2025 04:31 PM Drug Manufacturers - Specialty & Generic
Lowest Today 15.59
Highest Today 16.78
Today’s Open 15.63
Prev. Close 15.37
52 Week High 23.00
52 Week Low 11.09
Day’s Range: Low 15.59 High 16.78
52-Week Range: Low 11.09 High 23.00
1 day return -
1 Week return +2.54
1 month return -10.02
3 month return -6.08
6 month return -2.45
1 year return +36.22
3 year return +414.33
5 year return +102.32
10 year return -

Institutional Holdings

Opaleye Management Inc 10.66

EcoR1 Capital, LLC 7.57

BlackRock Inc 5.71

Vanguard Group Inc 4.89

Nantahala Capital Management, LLC 4.39

Vanguard Total Stock Mkt Idx Inv 2.56

iShares Russell 2000 ETF 2.33

Geode Capital Management, LLC 2.21

Morgan Stanley - Brokerage Accounts 1.90

Divisadero Street Capital Management, LP 1.86

Westside Investment Management, Inc. 1.76

Renaissance Technologies Corp 1.51

Cannell Capital LLC 1.45

Thompson, Siegel & Walmsley LLC 1.42

State Street Corp 1.21

Soleus Capital Management, L.P. 1.06

Vanguard Institutional Extnd Mkt Idx Tr 1.03

Northern Trust Corp 0.98

Fidelity Small Cap Index 0.96

JPMorgan Chase & Co 0.90

iShares Russell 2000 Growth ETF 0.83

Connor Clark & Lunn Inv Mgmt Ltd 0.83

Two Sigma Investments LLC 0.80

UBS Group AG 0.79

Aristides Capital LLC 0.62

Fidelity Extended Market Index 0.51

Vanguard Russell 2000 ETF 0.46

Bridgeway Ultra-Small Company 0.40

State St Russell Sm Cap® Indx SL Cl I 0.34

Calamos Timpani Small Cap Growth I 0.25

Schwab Small Cap Index 0.24

Timpani Small Cap Growth Equity 0.24

NT R2000 Index Fund - NL 0.23

iShares Micro-Cap ETF 0.22

Extended Equity Market Fund K 0.20

iShares Core S&P Total US Stock Mkt ETF 0.19

NT R2000 Index Fund - DC - NL - 3 0.18

Fidelity Total Market Index 0.18

iShares Russell 2000 Small-Cap Idx Instl 0.17

SPDR® Russell 2000 US Small Cap ETF 0.15

Market Status

Strong Buy: 2

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 412.19 M

PB Ratio 17.9162

PE Ratio 0.0

Enterprise Value 408.06 M

Total Assets 76.12 M

Volume 295367

Company Financials

Annual Revenue FY23:32827000 32.8M, FY22:21251000 21.3M, FY21:21832000 21.8M, FY20:39000 0.0M, FY19:959000 1.0M

Annual Profit FY23:23791000 23.8M, FY22:14318000 14.3M, FY21:19209000 19.2M, FY20:-247000 -0.2M, FY19:506000 0.5M

Annual Net worth FY23:2232000 2.2M, FY22:-9782000 -9.8M, FY21:-2961000 -3.0M, FY20:-28829000 -28.8M, FY19:-18039000 -18.0M

Quarterly Revenue Q3/2025:22459000 22.5M, Q2/2025:18928000 18.9M, Q1/2025:17282000 17.3M, Q3/2024:10324000 10.3M, Q2/2024:9074000 9.1M

Quarterly Profit Q3/2025:7855000 7.9M, Q2/2025:11924000 11.9M, Q1/2025:9861000 9.9M, Q3/2024:6302000 6.3M, Q2/2024:5626000 5.6M

Quarterly Net worth Q3/2025:-1927000 -1.9M, Q2/2025:-2585000 -2.6M, Q1/2025:-1572000 -1.6M, Q3/2024:627000 0.6M, Q2/2024:-3041000 -3.0M

Fund house & investment objective

Company Information Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-400 for treating adrenal insufficiency; ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Organisation Drug Manufacturers - Specialty & Generic

Employees 31

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Sean E. Brynjelsen

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow